Companies Cryptocurrencies
Exagen Inc
Exagen Inc
Exchange: NasdaqGS
IPO Date: 19/09/2019
CEO: Mr. Fortunato Rocca
Diagnostics & Research Healthcare 🔗
  • XGN
  • 5.31
  • 86342720
    market cap
  • 0.02999973
If you bought

shares of Exagen Inc (XGN) on
You would have made
Old Price $12 Current Price $12

Exagen, Inc. is a commercial-stage diagnostics company. The company is headquartered in Vista, California and currently employs 82 full-time employees. The firm offers physicians testing for patients and healthcare providers in diagnosis, prognosis and monitoring of autoimmune conditions. Its diagnostic tests include AVISE connective tissue disease (CTD), AVISE Lupus and AVISE antiphospholipid syndrome (APS). Its prognostic tests include AVISE systemic lupus erythematosus (SLE) Prognostic, AVISE Platelet-bound C4d (PC4d) and AVISE Anti- carbamylated proteins (CarP). Its monitoring tests include AVISE SLE Monitor, AVISE methotrexate (MTX) and AVISE hydroxychloroquine (HCQ).

Address: 1261 Liberty Way Ste C Vista CALIFORNIA 92081

Stay updated.